Boris Shore
President at NORTHERN POTASH CO.
Profile
Boris Shore is currently the President of Northern Potash Co. He previously worked as the Executive Director-Research & Development at Immune Pharmaceuticals, Inc. Dr. Shore obtained his undergraduate degree from Moscow University in 1971.
Boris Shore active positions
Companies | Position | Start |
---|---|---|
NORTHERN POTASH CO. | President | - |
Former positions of Boris Shore
Companies | Position | End |
---|---|---|
IMMUNE PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | - |
Training of Boris Shore
Moscow University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
NORTHERN POTASH CO. | Process Industries |
Private companies | 1 |
---|---|
Immune Pharmaceuticals, Inc.
Immune Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Immune Pharmaceuticals, Inc. is a biopharmaceutical company developing novel therapeutic agents for the treatment of immunologic and inflammatory diseases. Its lead product, Bertilimumab, is a human monoclonal antibody that binds eotaxin-1, a chemokine that attracts eosinophils to the site of inflammation. Bertilimumab has shown promising clinical activity in bullous pemphigoid and has been studied in other conditions including allergic rhinitis and ulcerative colitis, and may have application in other diseases, including atopic dermatitis, asthma, and other diseases. It is also developing NanoCyclo, a topical nano-encapsulated formulation of cyclosporine, for the treatment of atopic dermatitis (AD) and psoriasis. The company was founded by Daniel Gedeon Teper on March 9, 1993 and is headquartered in Englewood Cliffs, NJ. | Health Technology |
- Stock Market
- Insiders
- Boris Shore